MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 06.03.2024
Endo International plc Betriebsaufwand 2011-2025 | ENDP
Betriebsaufwand Jährlich Endo International plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 763 M | 832 M | 802 M | 954 M | 844 M | 950 M | 992 M | 1.12 B | 1.04 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.12 B | 763 M | 922 M |
Betriebsaufwand anderer Aktien in der Arzneimittelhersteller
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Assertio Holdings
ASRT
|
133 M | $ 0.66 | -0.02 % | $ 46.9 M |  USA |
 |
Alimera Sciences
ALIM
|
71.8 M | - | - | $ 142 M | USA |
 |
Canopy Growth Corporation
CGC
|
197 M | $ 1.31 | -6.43 % | $ 141 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
213 M | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
512 M | - | - | $ 11.5 B | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
40.3 M | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
154 M | $ 2.74 | -0.36 % | $ 1.44 B | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
38.9 M | - | 0.86 % | $ 117 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
113 M | - | -39.89 % | $ 27.7 M | USA |
 |
Evoke Pharma
EVOK
|
12.6 M | - | - | $ 36.6 M | USA |
 |
Agile Therapeutics
AGRX
|
30.5 M | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
183 M | $ 4.57 | -1.72 % | $ 86.3 M | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
213 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
106 M | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
44.6 M | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
558 M | $ 12.63 | 0.72 % | $ 647 M | USA |
 |
Athenex
ATNX
|
96.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
196 M | $ 21.58 | 0.19 % | $ 2.05 B |  France |
 |
Neoleukin Therapeutics
NLTX
|
55.6 M | - | - | $ 193 M | Canada |
 |
Evolus
EOLS
|
107 M | $ 6.85 | 0.59 % | $ 425 M | USA |
 |
Harrow Health
HROW
|
90.1 M | $ 50.16 | 2.05 % | $ 1.64 B | USA |
 |
China Pharma Holdings
CPHI
|
2.6 M | $ 1.31 | -1.5 % | $ 22.9 M |  China |
 |
OrganiGram Holdings
OGI
|
41.4 M | $ 1.76 | 1.15 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
368 M | $ 5.87 | 2.09 % | $ 773 M | USA |
 |
Pacira BioSciences
PCRX
|
279 M | $ 26.02 | 1.09 % | $ 1.2 B | USA |
 |
Bausch Health Companies
BHC
|
4.96 B | $ 7.18 | -1.91 % | $ 2.62 B | Canada |
 |
Lannett Company
LCI
|
209 M | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
35.2 M | $ 4.2 | -1.41 % | $ 59.1 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
9.18 M | $ 3.64 | 1.68 % | $ 4.52 M | USA |
 |
Radius Health
RDUS
|
304 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
22.5 M | - | -4.76 % | $ 65.3 M | USA |
 |
PetIQ
PETQ
|
138 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
104 M | $ 4.6 | 2.45 % | $ 138 M | USA |
 |
Jupiter Wellness
JUPW
|
39.6 M | - | - | $ 33.6 M | USA |
 |
Rockwell Medical
RMTI
|
31.1 M | $ 0.81 | -0.81 % | $ 18.9 M | USA |
 |
Perrigo Company plc
PRGO
|
1.43 B | $ 13.75 | 0.51 % | $ 1.89 B | USA |
 |
ProPhase Labs
PRPH
|
47.1 M | $ 0.62 | -10.48 % | $ 9.82 M | USA |
 |
Sundial Growers
SNDL
|
102 K | $ 1.77 | -0.56 % | $ 3.37 M | Canada |
 |
OptiNose
OPTN
|
129 M | - | - | $ 1.08 B | USA |
 |
cbdMD
YCBD
|
28.9 M | $ 1.59 | -4.22 % | $ 6.86 M | USA |
 |
Solid Biosciences
SLDB
|
130 M | $ 5.9 | - | $ 241 M | USA |
 |
PLx Pharma
PLXP
|
44.2 M | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
67.5 M | $ 0.6 | 1.78 % | $ 28.7 M | USA |
 |
Tricida
TCDA
|
153 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
1.52 B | $ 10.15 | -3.61 % | $ 6.27 B | Canada |
 |
TherapeuticsMD
TXMD
|
9.82 M | $ 1.7 | 3.66 % | $ 17.7 M | USA |
 |
Veru
VERU
|
44 M | $ 2.34 | 0.86 % | $ 316 M | USA |
 |
Viatris
VTRS
|
4.88 B | $ 12.24 | 1.83 % | $ 14.8 B | USA |
 |
Zomedica Corp.
ZOM
|
14.1 M | - | -0.21 % | $ 98 M | USA |